Afbrydelse af behandlingen på grund af bivirkninger skete for 7, 1% af celecoxibpatienterne og for 6, 1% af placebopatienterne.
Side-effects listed have a rate equal or greater than placebo, and the discontinuation rate due to side effects was 7.1% in patients receiving celecoxib and 6.1% in patients receiving placebo.